This episode breaks down how PBMs conduct inventory audits, the sourcing and timing issues that trigger recoupments, and how pharmacies can prepare and push back.
News|Articles|June 17, 2008
Humana loosens its drug refill rules following natural disasters
Humana members in areas affected by flooding or fires can get their refills filled earlier than usual.
Advertisement
In view of the storms, tornadoes, and/or flooding that have wreaked havoc in many states over the past few days,
- 55 counties in Iowa
- 30 counties in Wisconsin
- six counties in Illinois
- two counties in Minnesota
In addition, the same holds true for two counties in Northern California, which have been devastated by wildfires. Members with questions can call the toll-free number listed on the back of their Humana ID cards.
To see more Daily News articles,
To go to the Drug Topics homepage,
Advertisement
Related to this article
In part 2 of our discussion with Kimberly Kue-Tsemo, PharmD, she addresses the emergence of technology and the nuances behind its actual capabilities.
In part 2, Allison Schneider, MPH, discusses PBM and 340B reform that could compound pharmacies’ burden amid ongoing Medicare drug price negotiations.
Researchers provide an update on the adverse events of special interest following patients who received 2024–2025 Pfizer-BioNTech COVID-19 vaccination.
Type 1 and type 2 diabetes reports emphasize areas where pharmacists can act now, including CGM, cardio-kidney therapies, and equitable patient access.
Kimberly Kue-Tsemo, PharmD, explores the current state of US pharmacy deserts amid ongoing reform, evolution in practice, and more.
Alyssa Eisenberg, PharmD, discusses key industry challenges and developments as community pharmacists continue to impact patient outcomes across the US.
Allison Schneider, MPH, provides expertise on how IRA drug price negotiations have impacted pharmacies in 2026 and what’s to come in the years ahead.
Advertisement
Advertisement
Trending on Drug Topics
1
Updated Diabetes Consensus Shifts Focus from Glucose Control to Whole-Person Care
2
What the CLARITY Study Means for Counseling on Long-Acting HIV PrEP
3
Q&A: Overlapping PBM, 340B Reform Create Uncertainty for Pharmacies
4
No Added Adverse Event Risk in Pfizer-BioNTech COVID-19 Vaccine
5